APVO436
5002
Phase 1 mab active
Quick answer
APVO436 for AML is a Phase 1 program (mab) at Aptevo Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Aptevo Therapeutics
- Indication
- AML
- Phase
- Phase 1
- Modality
- mab
- Status
- active